Viking Therapeutics: Cooling Market Sentiments Surrounding GLP1s - Much Uncertainties Ahead
Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...
news.stocktradersdaily2d
When (LLY) Moves Investors should Listen
Check the time stamp on this data. Updated AI-Generated Signals for Eli Lilly And Company (LLY) available here: LLY. Type a ...
EconoTimes2d
Nicholas Wilson
EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...
Stock Of The Day: Lilly's Strong Support Level Signals Potential Rebound
Eli Lilly & Co. (LLY) is rebounding from Friday's sales disappointment, finding support at $722 and set for another uptrend.
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for ...
Chinese biotech dominance in R&D is on the rise
According to Evaluate Pharma, China's growing influence in pharmaceutical R&D is a key theme to watch in 2025. The pharma ...
Leerink Partnrs Has Bearish Outlook for LLY FY2024 Earnings
Equities researchers at Leerink Partnrs decreased their FY2024 earnings per share estimates for shares of Eli Lilly and ...